Gene Therapy Using rAAV Vector Against Hematological Disorders : From Basic Science To Clinical Application.
使用 rAAV 载体对抗血液疾病的基因治疗:从基础科学到临床应用。
基本信息
- 批准号:09671105
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Adeno associated virus (AAV) has been thought to be the promising vector for gene therapy because of its wide range of human tissues and low toxicity. We have recently initiated the study of rAAV for hematopoietic cells. Preliminary results revealed that the transduction efficiencies assessed by colony formation assay employing NeoR gene into various cell lines, were CML->AML->ALL-derived cell lines by log differences. Present study was performed using peripheral T cell as a target tissue. After purification and concentration of rAAV, 27% efficiency was observed in CML line at an MOI of 7 and a linear relationship between MOI and efficiency was confirmed, suggesting that this syatem may be useful for gene transduction into leukemia cells. Integration of the NeoR gene into the host genome was assessed by Southern blotting, that revealed various sizes of DNA fragments. A fluorescent in situ hybridization (FISH) analysis was perfomed on 11 clones, in all of which the NeoR gene was integrated out of chromosome 19. In five clones, chromosome painting probes showed that the integration sites were chromosome 1q, 2q, 2q, 11p, 12p and l3q.
由于其广泛的人体组织和低毒性,因此人们认为Adeno相关病毒(AAV)被认为是基因治疗的有前途的载体。我们最近启动了造血细胞的RAAV研究。初步结果表明,通过对数差异,通过cml--> aml->全源性细胞系评估,通过菌落形成分析评估的转导效率。目前的研究使用外周T细胞作为目标组织进行。在RAAV的纯化和浓度之后,在CML线的MOI处观察到27%的效率,MOI为7,MOI与效率之间的线性关系得到了证实,这表明该SYATEM对于基因转导向白血病细胞可能很有用。通过Southern印迹评估了Neor基因在宿主基因组中的整合,该印迹揭示了各种大小的DNA片段。将荧光原位杂交(FISH)分析在11个克隆上呈现,其中所有神经基因均从19号染色体中整合。在5个克隆中,染色体绘画探针表明,整合位点是1q,2q,2q,2q,11p,12p,12p和L3Q。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Iida H,Towatari M,Tanimoto M et al: "Overexpression of cyclin E in acute myelogenous leukemia" Blood. 90. 3707-13 (1997)
Iida H、Towatari M、Tanimoto M 等人:“急性髓性白血病中细胞周期蛋白 E 的过度表达”血液。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Iijima N,Miyamura K,Itou T,Tanimoto M et al: "Functional expression of Fas(CD95)in acute myeloid leukemia cells in the context of CD34 and CD38 expression: possible correlation with sensitivity to chemotherapy" Blood. 90. 4901-9 (1997)
Iijima N、Miyamura K、Itou T、Tanimoto M 等人:“在 CD34 和 CD38 表达背景下急性髓系白血病细胞中 Fas(CD95) 的功能表达:可能与化疗敏感性相关”血液。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Abe A,Emi N,Tanimoto M et al: "Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution." Blood. 90. 4271-7 (1997)
Abe A、Emi N、Tanimoto M 等人:“克隆进化后急性髓性白血病中血小板衍生生长因子受体 β 与新基因 CEV14 的融合。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Towatari M., Iida H., Tanimoto M, et al: "Costitutive Activation of Mitogen-Activated Protein Kinase Pathway in Acute Leukemia Cells" Leukemia. 11. 479-484 (1997)
Towatari M.、Iida H.、Tanimoto M 等人:“急性白血病细胞中丝裂原激活蛋白激酶途径的共同激活”白血病。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Abe A,Emi N,Tanimoto M et al: "Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution." Blood. 90. 4271-4277 (1997)
Abe A、Emi N、Tanimoto M 等人:“克隆进化后急性髓性白血病中血小板衍生生长因子受体 β 与新基因 CEV14 的融合。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
共 14 条
- 1
- 2
- 3
TANIMOTO Mitsune的其他基金
The role of PD1 pathway on tolerance after allogeneic transplantation
PD1通路对同种异体移植后耐受的作用
- 批准号:2459142524591425
- 财政年份:2012
- 资助金额:$ 2.05万$ 2.05万
- 项目类别:Grant-in-Aid for Scientific Research (C)Grant-in-Aid for Scientific Research (C)
Basic research of Adeno-associated virus (AAV) mediated gene transfer against human leukemia.
腺相关病毒(AAV)介导的基因转移抗人类白血病的基础研究。
- 批准号:0767119107671191
- 财政年份:1995
- 资助金额:$ 2.05万$ 2.05万
- 项目类别:Grant-in-Aid for Scientific Research (C)Grant-in-Aid for Scientific Research (C)
Dectection of leukemia-associate antioncogene located on the long-arm of human chromosome 9.
位于人类9号染色体长臂上的白血病相关抑癌基因的检测。
- 批准号:0467152004671520
- 财政年份:1992
- 资助金额:$ 2.05万$ 2.05万
- 项目类别:Grant-in-Aid for General Scientific Research (C)Grant-in-Aid for General Scientific Research (C)
相似海外基金
An adeno-associated virus based gene therapy treatment for diabetes: Using transcription factors to guide the expansion of insulin producing beta-cell mass in the pancreas
基于腺相关病毒的糖尿病基因疗法:利用转录因子引导胰腺中产生胰岛素的β细胞群的扩张
- 批准号:318286318286
- 财政年份:2014
- 资助金额:$ 2.05万$ 2.05万
- 项目类别:Studentship ProgramsStudentship Programs
BTK gene targeting in a hematopoietic stem cell using an adenovirus adeno-associate virus hybrid vector
使用腺病毒腺相关病毒杂交载体靶向造血干细胞中的 BTK 基因
- 批准号:2179099621790996
- 财政年份:2009
- 资助金额:$ 2.05万$ 2.05万
- 项目类别:Grant-in-Aid for Young Scientists (B)Grant-in-Aid for Young Scientists (B)
Adeno-associate virus (AAV) induces apoptosis of HIV-infected cells
腺相关病毒 (AAV) 诱导 HIV 感染细胞凋亡
- 批准号:1959048119590481
- 财政年份:2007
- 资助金额:$ 2.05万$ 2.05万
- 项目类别:Grant-in-Aid for Scientific Research (C)Grant-in-Aid for Scientific Research (C)
Evaluation of protective and adverse effects of gene transferred IPE cell transplantation on degenerative retinal diseases
基因转移IPE细胞移植对退行性视网膜疾病的保护作用和不良作用评价
- 批准号:1539052415390524
- 财政年份:2003
- 资助金额:$ 2.05万$ 2.05万
- 项目类别:Grant-in-Aid for Scientific Research (B)Grant-in-Aid for Scientific Research (B)
TREATMENT OF RETINAL DEGENERATIVE DISIESE BY TRANSPLANTATION OF GENE TRANSFERRED CELLS
基因转移细胞移植治疗视网膜退行性疾病
- 批准号:1235701012357010
- 财政年份:2000
- 资助金额:$ 2.05万$ 2.05万
- 项目类别:Grant-in-Aid for Scientific Research (A)Grant-in-Aid for Scientific Research (A)